NDC 70710-1699-2 - Venlafaxine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1699
- Requested NDC
- 70710-1699-2
- Package NDCs from labels
- 70710-1699-5, 70710-1699-0, 70710-1699-2, 70710-1699-4, 70710-1699-3, 70710-1699-9
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2026-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VENLAFAXINE - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Venlafaxine Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1699-0 | Venlafaxine Hydrochloride | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | 3 | |
| 70710-1699-2 | Venlafaxine Hydrochloride | 10 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 10 | 3 | |
| 70710-1699-3 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 3 | |
| 70710-1699-4 | Venlafaxine Hydrochloride | 10 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 10 | 3 | |
| 70710-1699-5 | Venlafaxine Hydrochloride | 500 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 500 | 3 | |
| 70710-1699-9 | Venlafaxine Hydrochloride | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1699 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS USA INC.] | 2 | Current NDC, 6 package rows | 20230905_9fda0f8d-b24e-4581-9dca-7aaaf86e2413.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1699-0 | EA - Each | 70710-1699 | 8f29174b-5928-46b7-87bf-6db9cce308f7 | 1 | 2024-04-05 |
| 70710-1699-9 | EA - Each | 70710-1699 | cea40c4a-925a-4aa8-8a92-9bc90ac71944 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RECHARGE Protect Blur | TITANIUM DIOXIDE, ZINC OXIDE | Rodan & Fields Beauty, LLC | c787e3b9-33b1-4c47-95bd-b14cf6558938 | 2025-12-08 | Warnings | 15FIX9V2JP |
| Mineral Mist SPF-50 | TITANIUM DIOXIDE, ZINC OXIDE | TUBBY TODD | dca54a19-af25-ce47-e053-2a95a90a22db | 2025-12-07 | Warnings | 15FIX9V2JP |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | QPharma, Inc. | 9e745ad7-be4f-4369-be23-587e1154e4ab | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 313585 7D7RX5A8MO |
| Solbar Shield SPF40 | SOLBAR SHIELD SPF40 | Person and Covey | bd3a9a94-fc87-4127-abf9-29e56ac9ce5d | 2025-12-04 | Warnings | 15FIX9V2JP |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | 0a1b6bcd-8d46-44ab-bc5d-65515601d2ff | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | 313581 7D7RX5A8MO |
| Biossance Squalane and Daily Mineral Sunscreen Broad Spectrum SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | THG Beauty USA LLC | 44952d01-7f38-0a9c-e063-6394a90a2018 | 2025-11-27 | Warnings | 15FIX9V2JP |
| Venlafaxine | VENLAFAXINE | Ajanta Pharma USA Inc. | 22d4817c-1f19-4490-8a38-d8904f0374f7 | 2025-11-27 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| salmon colored sunscreen | SALMON COLORED SUNSCREEN | Guangzhou Fantesy Biotechnology Co.,Ltd | 4477964b-28f3-a371-e063-6294a90a4230 | 2025-11-25 | Warnings | 15FIX9V2JP |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 349308ef-2caf-4fec-b428-56ae06c6771d | 2025-11-25 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| it cosmetics Bye Bye Foundation Full Coverage Moisturizer with 3D Skin Flex Broad Spectrum SPF 50 Plus UVA UVB Physical Sunscreen All Shades | TITANIUM DIOXIDE AND ZINC OXIDE | L'Oreal USA, Inc. | 86eea4df-4191-4e05-9f05-4a98ef8c2a4d | 2025-11-24 | Warnings | 15FIX9V2JP |
| Cetaphil Sun Tinted Face SPF 40 | TITANIUM DIOXIDE, ZINC OXIDE | Galderma Laboratories, L.P. | 22413f93-7219-4726-b741-2392e576b34a | 2025-11-24 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.